#Autoinjectors market was valued at USD 1,100 million in 2022 and is expected to reach USD 2,491 million by 2033, growing at a CAGR of 13.5%. Autoinjectors, used for easy self-administration of medication, are gaining traction in treating chronic conditions like rheumatoid arthritis, multiple sclerosis, and diabetes. Read More: https://wemarketresearch.com/reports/autoinjectors-market/1195 #HealthcareInnovation #MedicalDevices #ChronicDiseaseCare #SelfInjection #PharmaTrends